Zymeworks (ZYME) Change in Cash (2021 - 2026)
Zymeworks (ZYME) reported Change in Cash of $203.1 million for Q1 2026, up 1910.94% on a YoY basis from $10.1 million in Q1 2025, and up 957.9% sequentially from -$23.7 million in Q4 2025.
Zymeworks (ZYME) Change in Cash (2021 - 2026) Analysis & Trends
Zymeworks (ZYME) has 6 years of Change in Cash data on file, last reported at $203.1 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash rose 1910.94% year-over-year to $203.1 million; the trailing twelve-month figure through Mar 2026 stood at $168.1 million (up 535.32% YoY), and the FY2025 full-year result was -$24.9 million, up 72.72% from the prior year.
- Change in Cash climbed to $203.1 million in Q1 2026, from -$23.7 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $304.8 million in Q4 2022 to a low of -$219.3 million in Q1 2023.
- A 5-year average of $2.5 million and a median of -$33.4 million in 2025 frame the typical range for Change in Cash.
- Across the five-year window, Change in Cash slumped 397.8% in 2023 and jumped 1910.94% in 2026, its largest moves.
- Tracing ZYME's Change in Cash over 5 years: stood at $304.8 million in 2022, then sank by 79.26% to $63.2 million in 2023, then tumbled by 188.97% to -$56.3 million in 2024, then jumped by 57.91% to -$23.7 million in 2025, then soared by 957.9% to $203.1 million in 2026.
- Business Quant data shows ZYME's Change in Cash at $203.1 million in Q1 2026, -$23.7 million in Q4 2025, and -$33.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.44 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 243.78 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 57.19 Mn |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - | 203.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 203.13 Mn |
| Dec 31, 2025 | -23.68 Mn |
| Sep 30, 2025 | -33.42 Mn |
| Jun 30, 2025 | 22.05 Mn |
| Mar 31, 2025 | 10.10 Mn |
| Dec 31, 2024 | -56.25 Mn |
| Sep 30, 2024 | 51.39 Mn |
| Jun 30, 2024 | -43.85 Mn |
| Mar 31, 2024 | -42.74 Mn |
| Dec 31, 2023 | 63.23 Mn |
| Sep 30, 2023 | -47.77 Mn |
| Jun 30, 2023 | -39.48 Mn |
| Mar 31, 2023 | -219.33 Mn |
| Dec 31, 2022 | 304.83 Mn |
| Sep 30, 2022 | -102.57 Mn |
| Jun 30, 2022 | -76.87 Mn |
| Mar 31, 2022 | 73.65 Mn |
| Dec 31, 2021 | -51.57 Mn |